Consensus Nicox SA Boerse Muenchen

Stocks

NXOA

FR0013018124

Pharmaceuticals

Market Closed - Boerse Muenchen 16:43:09 2026-09-11 EDT			5-day change	1st Jan Change
0.4500 ^EUR	0.00%		+24.31%	+51.26%

09-11	Chinese Regulator Accepts Nicox's Glaucoma Drug Application for Review	MT
09-11	Nicox S.A. Announces Acceptance Of NCX 470 NDA For Review In China	CI

Evolution of the Average Target: Nicox SA

Data source: Nicox SA(ALCOX)

Evolution of the Target Price: Nicox SA

Data source: Nicox SA(ALCOX)

Changes in Analyst Recommendations: Nicox SA

Data source: Nicox SA(ALCOX)

a3b90939ead72b7803b926607f.2YWMP7sv9tbgm_IoUfWYTkIquTLdB1NwnV3T32oqP1Q.m7S5V4lXjLWSzIFPIrn9DDh53mepQQIZyxqHkiATSwKRs-1n_HaFn9PKqw~af267d8313979b0d498c49eef06ece0c

Specialty & Advanced Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	NICOX SA		-	-	-	-
	MERCK & CO., INC.					+6.28%
	MERCK KGAA					+17.32%
	HALOZYME THERAPEUTICS, INC.					-7.13%
	KYOWA KIRIN CO., LTD.					+4.12%
	SK BIOPHARMACEUTICALS CO., LTD.					+64.15%
	YUHAN CORPORATION					+47.58%
	BETTA PHARMACEUTICALS CO., LTD.			-	-	-11.87%
	SUPERNUS PHARMACEUTICALS, INC.					+48.29%
	Average					+21.09%
	Weighted average by Cap.					+8.59%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.3440EUR

Average target price

1.000EUR

Spread / Average Target

+190.70%

High Price Target

1.000EUR

Spread / Highest target

+190.70%

Low Price Target

1.000EUR

Spread / Lowest Target

+190.70%

Analyst Consensus Detail

Consensus revision (last 18 months)

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!